[EN] PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS<br/>[FR] COMPOSÉS DE PYRAZOLYL PYRIMIDINYLAMINE EN TANT QU'INHIBITEURS DE CDK2
申请人:INCYTE CORP
公开号:WO2020180959A1
公开(公告)日:2020-09-10
The present application provides pyrazolyl pyrimidinylamine inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.